Group One Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,600
| Closed | -$26K | – | 8615 |
|
|
2024
Q4 | $26K | Buy |
48,600
+17,000
| +54% | +$11.8K | ﹤0.01% | 5525 |
|
|
2024
Q3 | $55.6K | Buy |
31,600
+2,700
| +9% | +$3.77K | ﹤0.01% | 4593 |
|
|
2024
Q2 | $33.8K | Sell |
28,900
-1,200
| -4% | -$3K | ﹤0.01% | 4820 |
|
|
2024
Q1 | $272K | Sell |
30,100
-92,200
| -75% | -$896K | ﹤0.01% | 3293 |
|
|
2023
Q4 | $1.33M | Buy |
122,300
+42,900
| +54% | +$322K | ﹤0.01% | 2198 |
|
|
2023
Q3 | $639K | Buy |
79,400
+33,800
| +74% | +$281K | ﹤0.01% | 2680 |
|
|
2023
Q2 | $495K | Buy |
45,600
+15,400
| +51% | +$132K | ﹤0.01% | 3031 |
|
|
2023
Q1 | $208K | Buy |
30,200
+2,100
| +7% | +$13.2K | ﹤0.01% | 3628 |
|
|
2022
Q4 | $112K | Buy |
28,100
+2,000
| +8% | +$9.83K | ﹤0.01% | 4340 |
|
|
2022
Q3 | $174K | Buy |
26,100
+18,400
| +239% | +$113K | ﹤0.01% | 4277 |
|
|
2022
Q2 | $37K | Sell |
7,700
-800
| -9% | -$4.87K | ﹤0.01% | 5822 |
|
|
2022
Q1 | $79K | Sell |
8,500
-74,600
| -90% | -$741K | ﹤0.01% | 5725 |
|
|
2021
Q4 | $987K | Buy |
83,100
+4,900
| +6% | +$56.6K | ﹤0.01% | 3373 |
|
|
2021
Q3 | $890K | Buy |
78,200
+400
| +0.5% | +$5.5K | ﹤0.01% | 3545 |
|
|
2021
Q2 | $1.4M | Buy |
77,800
+52,600
| +209% | +$846K | ﹤0.01% | 3033 |
|
|
2021
Q1 | $390K | Sell |
25,200
-29,200
| -54% | -$422K | ﹤0.01% | 4326 |
|
|
2020
Q4 | $664K | Sell |
54,400
-40,800
| -43% | -$569K | ﹤0.01% | 3032 |
|
|
2020
Q3 | $1.22M | Buy |
95,200
+81,975
| +620% | +$707K | ﹤0.01% | 2016 |
|
|
2020
Q2 | $134K | Buy |
13,225
+1,000
| +8% | +$9.2K | ﹤0.01% | 3681 |
|
|
2020
Q1 | $99K | Buy |
12,225
+5,625
| +85% | +$48.7K | ﹤0.01% | 3303 |
|
|
2019
Q4 | $57K | Sell |
6,600
-3,025
| -31% | -$17K | ﹤0.01% | 3950 |
|
|
2019
Q3 | $59K | Sell |
9,625
-18,925
| -66% | -$153K | ﹤0.01% | 3899 |
|
|
2019
Q2 | $474K | Buy |
28,550
+16,150
| +130% | +$280K | ﹤0.01% | 2183 |
|
|
2019
Q1 | $207K | Buy |
12,400
+1,175
| +10% | +$16.9K | ﹤0.01% | 2674 |
|
|
2018
Q4 | $129K | Sell |
11,225
-2,600
| -19% | -$52.6K | ﹤0.01% | 3010 |
|
|
2018
Q3 | $553K | Sell |
13,825
-23,300
| -63% | -$663K | ﹤0.01% | 2194 |
|
|
2018
Q2 | $1.05M | Buy |
37,125
+11,650
| +46% | +$258K | 0.01% | 1682 |
|
|
2018
Q1 | $389K | Buy |
25,475
+23,175
| +1,008% | +$552K | ﹤0.01% | 2256 |
|
|
2017
Q4 | $75K | Buy |
+2,300
| New | +$62K | ﹤0.01% | 3524 |
|
Group One Trading's MRNS Position: Q1 2025 in Review
Group One Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 6,310 shares — an estimated $3.38K sold.
Group One Trading first reported a position in MRNS in Q4 2017 and held it in 27 quarters. The position peaked at $1.36M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Group One Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 6,310 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $3.38K.
- Group One Trading first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 27 quarters.
- Group One Trading's Marinus Pharmaceuticals, Inc position peaked at $1.36M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.